Daré Bioscience, Inc. (DARE)
0.80
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 13:03
Daré Bioscience Shareholders Equity (Quarterly) : -0.5601M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5601M |
| March 31, 2026 | 0.7345M |
| December 31, 2025 | 2.843M |
| September 30, 2025 | 2.858M |
| June 30, 2025 | -12.73M |
| March 31, 2025 | -9.564M |
| September 30, 2024 | -1.484M |
| June 30, 2024 | 2.672M |
| March 31, 2024 | -11.00M |
| December 31, 2023 | -5.048M |
| September 30, 2023 | -2.289M |
| June 30, 2023 | -2.719M |
| March 31, 2023 | 4.972M |
| December 31, 2022 | 11.11M |
| September 30, 2022 | 26.34M |
| June 30, 2022 | 33.03M |
| March 31, 2022 | 30.88M |
| December 31, 2021 | 38.75M |
| September 30, 2021 | 31.89M |
| June 30, 2021 | 7.744M |
| March 31, 2021 | 3.258M |
| December 31, 2020 | -1.152M |
| September 30, 2020 | -1.386M |
| June 30, 2020 | 0.3113M |
| March 31, 2020 | 3.214M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.4408M |
| September 30, 2019 | 1.81M |
| June 30, 2019 | 5.083M |
| March 31, 2019 | 3.780M |
| December 31, 2018 | 6.727M |
| September 30, 2018 | 9.584M |
| June 30, 2018 | 12.22M |
| March 31, 2018 | 15.82M |
| December 31, 2017 | 13.29M |
| September 30, 2017 | 22.43M |
| June 30, 2017 | 4.059M |
| March 31, 2017 | 7.741M |
| December 31, 2016 | 13.11M |
| September 30, 2016 | 16.62M |
| June 30, 2016 | 25.84M |
| March 31, 2016 | 35.98M |
| December 31, 2015 | 48.74M |
| September 30, 2015 | 58.64M |
| June 30, 2015 | 68.20M |
| March 31, 2015 | 40.41M |
| December 31, 2014 | 45.32M |
| September 30, 2014 | 52.53M |
| June 30, 2014 | 57.81M |
| March 31, 2014 | -15.51M |
| December 31, 2013 | 58.67M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 903.12M |
| Elite Pharmaceuticals, Inc. | 104.83M |
| Eton Pharmaceuticals, Inc. | 46.58M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.37M |
| Total Liabilities (Quarterly) | 22.93M |
| Debt to Equity Ratio | -12.08 |
| Current Ratio | 0.986 |
| Net Debt Paydown Yield | 1.03% |